Frédéric Porte

Mr. Porte joined Genesys in 2008.
He is a seasoned entrepreneur and businessman with several years of experience in the life sciences industry.
During his career, he has founded 3 successful companies.
Mr. Porte is currently the President and Founder of Medipress Management Inc., a firm offering financial and strategic services to healthcare and venture capital organizations for the evaluation of M&A and strategic alliances.
Prior to that, he founded in 1987 Clinidata, a software and communication company developed in association with Royal Bank Capital Corporation and specialized in healthcare applications.
Clinidata developed effective and sophisticated technologies supported by multinational corporations such as Merck, Pfizer, J&J, Schering Plough and Smith Kline Beecham, combined with strategic alliances with managed care organizations and professional associations.
The company was acquired in 1994 by the pharmaceutical company Hoechst Marion Roussel.
In 1980, he created and managed L'Actualité Médicale, a leading Canadian medical publishing company which was later acquired by MacLean Hunter.
Mr. Porte has a degree in Business Administration and Finance from l'école Supérieure de Commerce de Lyon (France) and a D.E.A.
in Information Sciences from the University of Sorbonne (France).
He is a member of the Board of Directors of Labopharm Inc. He is also a director of Angelus Investment Corporation.